Sativex sublingual cannabis extract spray: Named-patient program data

Data from a 4-week, double-blind, U.K. withdrawal study in 36 patients showed that Sativex met the primary endpoint of time to treatment failure vs. placebo (p=0.013). Patient global impression of cha...